David W. Meline

CIK: 0001444612

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

HPQ

HP INC

Director

EIKN

Eikon Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

HPQ
HP INC
Apr 16, 2026
Award(A)
Restricted Stock Units
Direct
12.2K shares-
HPQ
HP INC
Apr 14, 2025
Award(A)
Restricted Stock Units
Direct
9.6K shares-

		Type	Shares	Price		Ownership
Apr 16, 2026	HPQ HP INC	Award(A) Restricted Stock Units	12,176	-	-	Direct
Apr 14, 2025	HPQ HP INC	Award(A) Restricted Stock Units	9,568	-	-	Direct

1-2 of 2 transactions

About Meline David W

Meline David W (SEC CIK 0001444612) files insider reports with the SEC as Director of HP INC (HPQ) and Director of Eikon Therapeutics, Inc. (EIKN).

Signal8 holds 3 ownership filings by Meline David W (1 Form 3, 2 Form 4), filed between Apr 16, 2025 and Apr 20, 2026. Those filings report 2 transactions, from Apr 14, 2025 to Apr 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Meline David W's filings is in PALO ALTO, CA.

Recent filings by Meline David W

Apr 16, 2026: Grant or award of HPQ derivative securities (Form 4, code A).
Apr 14, 2025: Grant or award of HPQ derivative securities (Form 4, code A).

Other insiders filing for HP INC (HPQ)

BROUSSARD BRUCE D, Interim CEO
Olson Anneliese, Pres Imaging Prtng & Solutions
Patel Ketan M, President, Personal Systems
McQuarrie David P., Chief Commercial Officer
Francisco Ma. Fatima, Director
PARKHILL KAREN L, Chief Financial Officer

How to read Form 4 transaction codes